Skip to content
Menu

GeneDx Holdings Corp. WGS

Full chart Compare
Set alert

Price alert · WGS

All alert types
51.96 USD 0.00 (+0.00%)

Regular-session close

53.00 +1.04 +2.00%

Pre-market · Nov 19, 8:44 AM ET

46.47 Day range 53.38
32.21 52-week range 170.87
YTD
-60.05%
1 year
-59.06%

5D -1.55 (-2.91%)

455055ThuFriMonTueWed51.68
Market cap
1.56B
Revenue (ttm)
460.78M
Profit margin
-24.10%
EPS (ttm)
-3.76
Shares out
29.97M
Forward P/E
36.34
YTD return
-60.05%
1-year return
-59.06%
50-day average
73.13
200-day average
69.67
Volume
1.71M
Avg volume
856.46K
Open
46.47
Previous close
51.96
Day's range
46.47 – 53.38
52-week range
32.21 – 170.87
Beta
1.99
Analysts
Strong Buy
Price target
82.00 (+57.8%)
Earnings date
Feb 22, 2027

Key statistics

Enterprise value
1.57B
Price / sales
3.08
Price / book
5.79
Revenue growth
5.40%
Free cash flow
-70.29M
Total cash
170.12M
Total debt
215.38M
Return on equity
-41.36%
Short % of float
41.71%

Fundamental scorecard

7 of 25 checks passed on WGS’s reported financials

ValueGrowthProfitabilityHealthDividend

7of 25 checks passed

  • Value 1 of 5
  • Growth 2 of 5
  • Profitability 1 of 5
  • Financial health 3 of 5
  • Dividend 0 of 5

Statements to Sep 30, 2026.

Financials — quick view

All financials
WGS Revenue — quarterly 123.10M
WGS Net income — quarterly -12.33M
WGS EPS — quarterly -0.41

Earnings

WGS recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 22, 2027Dec 30, 20260.40———
Nov 9, 2026Sep 30, 20260.072860.28+0.21+284.30%
Aug 3, 2026Jun 30, 2026-0.187870.01+0.20+105.32%
May 4, 2026Mar 31, 2026-0.06-0.28-0.22-366.67%
Feb 23, 2026Dec 31, 20250.110.14+0.03+27.27%
Oct 28, 2025Sep 30, 20250.280.49+0.21+75.00%

Upgrades / downgrades

WGS analyst upgrades and downgrades
DateFirmActionFromTo
Nov 10, 2026BTIGmainBuyBuy
Oct 1, 2026GuggenheimmainBuyBuy
Aug 4, 2026Canaccord GenuitymainBuyBuy
Aug 4, 2026BTIGreitBuyBuy
Jun 29, 2026GuggenheimmainBuyBuy
Jun 23, 2026Piper SandlermainOverweightOverweight

About GeneDx Holdings Corp.

GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.

Sector
Healthcare
Industry
Diagnostics & Research
Country
United States
Website
genedx.com

News

Your note

Sign in to keep a note on WGS — it syncs with the Stock Master app.

Insider holders

WGS insider holders
InsiderRelationLatest transactionDateShares held
CASDIN CAPITAL, LLCBeneficial Owner of more than 10% of a Class of SecurityPurchaseJun 4, 20260
CASDIN ELIDirector and Beneficial Owner of more than 10% of a Class of SecurityConversion of Exercise of derivative securityJun 17, 20264,083,650
FEELEY KEVINChief Financial OfficerSaleSep 8, 202641,476
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAIBeneficial Owner of more than 10% of a Class of SecuritySaleNov 17, 20242,719,690
LEPROUST EMILY MDirectorConversion of Exercise of derivative securityJun 17, 202624,852
MEISTER KEITH ADirector and Beneficial Owner of more than 10% of a Class of SecurityConversion of Exercise of derivative securityJun 17, 20265,141,420

Institution ownership

WGS institution ownership
Holder% heldSharesValueReported
Corvex Management LP15.96%4,784,570226.26MSep 29, 2026
Casdin Capital, LLC12.37%3,707,164175.31MSep 29, 2026
Goldman Sachs Group Inc7.02%2,102,78099.44MSep 29, 2026
ARK Investment Management, LLC6.38%1,913,12390.47MSep 29, 2026
Blackrock Inc.5.65%1,693,93180.11MSep 29, 2026
William Blair Investment Management, LLC5.21%1,560,24773.78MSep 29, 2026

Fund ownership

WGS fund ownership
Holder% heldSharesValueReported
ARK ETF Trust-ARK Innovation ETF3.08%924,52843.72MOct 30, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund2.03%607,77328.74MJun 29, 2026
ARK ETF Trust-ARK Genomic Revolution ETF1.78%533,97325.25MOct 30, 2026
iShares Trust-iShares Russell 2000 ETF1.73%518,23524.51MSep 29, 2026
MUTUAL FUND SERIES TRUST-Eventide Gilead Fund0.89%266,04212.58MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund0.83%249,89011.82MJun 29, 2026